Subscribe to Newsletter

Search

Reset Filter

154 search results for ‘mrna vaccine’

Business & Regulation Profession

Meeting Bob Pinco

| Stephanie Vine | 4 min read

From chasing drug lords to advising US presidents, it’s fair to say Robert Pinco has enjoyed a varied career.

Manufacture Bioprocessing - Upstream & Downstream

The Case for MMC

| Heidi Jones | 8 min read

The use of multimodal chromatography is increasing in biopharma purification processes. Here’s why.

Discovery & Development Drug Delivery

The VLP Promise

| Nicholas (Nik) Barbet | 4 min read

Here’s why virus-like particles could open a new chapter in combating disease.

Business & Regulation Trends & Forecasts

March’s Top Biopharma Headlines

| Stephanie Vine

The Medicine Maker’s round up of the top news stories in the pharma industry in March.

Discovery & Development Drug Discovery

QTOF: Quick Off the Mark for Oligonucleotide Analysis

| Timo Schierling, Julia Schneider, Stephan Seiffert, Christian Albers | 4 min read

Experts from Axolabs GmbH and Bruker Daltonics explain the benefits behind mass spectrometry for oligonucleotides in drug discovery

Discovery & Development Formulation

The Formulation Complex

| Thomas R. Tice, Firouz Asgarzadeh, Norbert Maurer, and Anthony J. Hickey

Experts discuss the trends and challenges in the development of complex dosage forms.

Business & Regulation COVID-19

Astra-Amplifiers

| Angus Stewart

Setting its sights on self-amplifying RNA, AstraZeneca has signed a deal with Imperial College London spinoff VaxEquity.

Manufacture Technology and Equipment

The Innovation Awards 2021

It’s time to celebrate The Medicine Maker annual Innovation Awards! Here, we showcase the top technologies released during 2021.

Discovery & Development Formulation

The Need for Novel Excipients

| Stephanie Vine | 6 min read

Keith Horspool reflects on the efforts that led the FDA to launch its pilot review program for novel excipients

Manufacture Contract Manufacturing Services

Weathering the Storm Together - Part 1

| Stephanie Vine

The efforts of CDMOs have been absolutely crucial in the pandemic response. We ask five CDMO gurus how they reacted to COVID-19.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

May Issue of The Medicine Maker